NovoCure Ltd — Director's Dealing 2019

Jan 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-10

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-10	Ordinary Shares	M	54930	$14.37	Acquired	201488	Direct
2019-01-10	Ordinary Shares	S	20880	$40.469	Disposed	180608	Direct
2019-01-10	Ordinary Shares	S	34050	$41.14	Disposed	146558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-10	Options to Buy Ordinary Shares	$14.37	M	54930	Disposed	2025-02-23	Ordinary Shares (54930)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,880 shares in multiple trades at prices ranging from $40.00 to $40.99. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 34,050 shares in multiple trades at prices ranging from $41.00 to $41.45. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: Fully vested as of the date hereof.